Latest Interviews

ZÜBLIN STRABAG CHILE

“I am convinced that our appreciation towards our great teams with open and transparent communication and our customer centricity are key to success.”

GOVERNMENT OF CHILE

“We would like exploration to open the door to new developments, so we aim to make the necessary regulatory changes to increase legal certainty for those who are willing to invest in exploration.”

APAC LANXESS

"The strong recovery in the automotive sector has contributed significantly to our growth, and so did our engineering materials segment, which includes both our high-performance materials and urethane systems business units."

CONSYNANCE THERAPEUTICS

"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."

OYSTER POINT PHARMA

"Our mission is to bring novel and transformative therapies to the anterior (front) chamber of the eye, particularly for the treatment of ocular surface disease."

AC IMMUNE

"AC Immune is combining diagnostics and therapeutics, and it has developed the tools to enable detection and clearance of specific pathological proteins underlying neurodegenerative diseases."